A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Lonafarnib | CAS 193275-84-2 - Request Quote

Picture of Lonafarnib
SZ CAT No:SZ-L104001
CAS No
193275-84-2
Mol.F.
C27H31Br2ClN4O2
Mol.Wt.
638.8
Inv. Status
Synthesis on demand
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Lonafarnib is chemically (R)-4-(2-(4-(3,10-Dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperidin-1-yl)-2-oxoethyl)piperidine-1-carboxamide. Lonafarnib is supplied with detailed characterization data compliant with regulatory guideline. Lonafarnib can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lonafarnib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 193275-84-2

Purchase 193275-84-2

Order 193275-84-2

Enquire 193275-84-2

price of 193275-84-2

193275-84-2 Supplier

193275-84-2 Manufacturer

193275-84-2 Exporter

buy high quality Lonafarnib

Purchase Lonafarnib

Lonafarnib suppliers

Lonafarnib manufacturers

Lonafarnib price

Order Lonafarnib

Enquire Lonafarnib

Lonafarnib cost

Lonafarnib Supplier

Lonafarnib Distributor

Lonafarnib for Method Validation

Lonafarnib Reference Standard

Lonafarnib for ANDA Filing

Lonafarnib for Forced Degradation Studies

Lonafarnib Identification Standards

Lonafarnib for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,